Immunotherapy Today

Immunotherapy News From Around The World

Immunotherapy

  • Miles to Go Before We Sleep — Dr. Richard Goldberg on Curing Colorectal Cancer - Oncodaily
  • Top Immunotherapy Trials to Watch at ASCO 2026 - Oncodaily
  • Comprehensive Genomic Profiling Broadens Treatment Options in Community Care - Targeted Oncology
  • Exploring a New Era of Treatment for Smoldering Myeloma - Targeted Oncology
  • Rethinking FDA Metrics for Immuno-Oncology Agents - Targeted Oncology
  • Rare but Targetable: Advances in Biliary Tract Cancer - Targeted Oncology
  • Unleashing natural killer cells against cancer - McGill University
  • The Sequencing Dilemma in Thyroid Cancer - Targeted Oncology
  • Understanding Melanoma and What It Means for Patients - Cure Today
  • Eli Lilly Bolsters CAR T-Cell Immunotherapy Pipeline With Kelonia Acquisition – And It’s Paying $7B - Stocktwits
  • ATOMIC Trial: Immunotherapy for Colon Cancer - Cure Today
  • How Immunotherapy Works and Its Common Skin Side Effects - Cure Today
  • Navigating the Complexities of SCLC Treatment Through the Lines of Therapy - Targeted Oncology
  • Pancreatic Cancer Vaccine Shows Durable Response for Six Years - Cancer Health
  • Understanding the ATOMIC Trial: Immunotherapy’s Impact in Stage III dMMR Colon Cancer - Cure Today
  • Future-Proofing Treatment in Younger Patients With CLL - Targeted Oncology
  • Dr Nabil Saba on Optimizing Anaplastic Thyroid Cancer Outcomes - Targeted Oncology
  • Novel KIR‑CAR T Approach Shows Early Activity Against Solid Tumors - Genetic Engineering and Biotechnology News
  • She Wrote Goodbye Letters after a Stage 4 Diagnosis: Immunotherapy Changed Her Plans - CRI - Oncodaily
  • New Immunotherapy Trial Shows 100% Success Rate Against One Type of Bowel Cancer - ZME Science
ImmunoTherapyToday.com is a global news aggregation platform dedicated to disseminating information about research and scientific discoveries from the transformative Immunotherapy scientific research community, as well as legal, business and regulatory news pertaining to the field.
Affiliated with CRISPRInsider.com
Skype interview, April 15, 2018
Oriana Sousa of Marinha Grande, Portugal was diagnosed in 2012 with an aggressive form of Small Cell Ovarian Cancer, and after several years of downturn and discouragement, was unexpectedly "cured" through immunotherapy. She has been in total remission for two years. This is her story.

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
    August 9, 2018
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
    July 13, 2018
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
    July 12, 2018
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
    July 9, 2018
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
    July 3, 2018
  • JITC tumor and cancer immunotherapy papers collection
    June 29, 2018
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
    June 21, 2018
  • Immunotherapy shows promise for advanced lymphoma: study
    June 17, 2018
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
    June 15, 2018
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
    June 15, 2018
  • …to develop and commercialize hpv pre-cancer immunotherapy …
    May 31, 2018
  • Atara Biotherapeutics Expands T-Cell Immunotherapy …
    May 23, 2018
  • Inovio’s DNA Immunotherapy Demonstrates Immune Response …
    May 17, 2018
  • Immune Design Reports, Data Update for Lead Immunotherapy …
    April 29, 2018
  • …of U. S. firm providing immunotherapy for prostate cancer
    April 22, 2018
  • …numbers predict response to combination immunotherapy in …
    April 22, 2018
  • Immunotherapy shows promise in type 1 diabetes clinical trial…
    April 22, 2018

Contact

[recaptcha]

Copyright 2018 ImmunoTherapyToday.com